Strict Quality-Control Standards: Manufactured and handled using research-focused procedures
The formal contraindications to treatment with the inhibitors of alpha-glucosidase are intestinal malabsorption syndromes, inflammatory bowel disease, intestinal obstruction, and liver failure
They warned, however, that even brief periods of discontinuation or interrupted use may progressively erode cardiovascular protection, which could then ultimately be reversed, increasing the risk of major adverse cardiovascular events
Patients should report any suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or via the Yellow Card app)
Important Considerations for Patients and Clinicians As we explore the potential of GLP-1 receptor agonists (GLP-1 RAs) for mood support, it's really important for both patients and their doctors to have a clear picture of what this means